Mitochondrial dysfunction in human skeletal muscle biopsies of lipid storage disorder

Abstract

Mitochondria regulate the balance between lipid metabolism and storage in the skeletal muscle. Altered lipid transport, metabolism and storage influence the bioenergetics, redox status and insulin signalling, contributing to cardiac and neurological diseases. Lipid storage disorders (LSDs) are neurological disorders which entail intramuscular lipid accumulation and impaired mitochondrial bioenergetics in the skeletal muscle causing progressive myopathy with muscle weakness. However, the mitochondrial changes including molecular events associated with impaired lipid storage have not been completely understood in the human skeletal muscle. We carried out morphological and biochemical analysis of mitochondrial function in muscle biopsies of human subjects with LSDs (n = 7), compared to controls (n = 10). Routine histology, enzyme histochemistry and ultrastructural analysis indicated altered muscle cell morphology and mitochondrial structure. Protein profiling of the muscle mitochondria from LSD samples (n = 5) (vs. control, n = 5) by high-throughput mass spectrometric analysis revealed that impaired metabolic processes could contribute to mitochondrial dysfunction and ensuing myopathy in LSDs. We propose that impaired fatty acid and respiratory metabolism along with increased membrane permeability, elevated lipolysis and altered cristae entail mitochondrial dysfunction in LSDs. Some of these mechanisms were unique to LSD apart from others that were common to dystrophic and inflammatory muscle pathologies. Many differentially regulated mitochondrial proteins in LSD are linked with other human diseases, indicating that mitochondrial protection via targeted drugs could be a treatment modality in LSD and related metabolic diseases. Cover Image for this Issue: doi: 10.1111/jnc.14177.

Leucine Supplementation: A Novel Strategy for Modulating Lipid Metabolism and Energy Homeostasis

“…In particular, increased mitochondrial content and function is closely associated with enhanced oxidative capacity of muscle fibers, leading to an improved muscle health and overall health and well-being [75]. Conversely, mitochondrial dysfunction in the skeletal muscle is a major predisposing factor for obesity and its related metabolic disorders [76]. Thus, maintaining abundant and functional mitochondria in the skeletal muscle is of great importance for sustained health.…”

Update Review about Metabolic Myopathies

“…Lipid storage diseases are characterized by the impaired digestion of triglycerides with a consecutive increase in cytosolic lipid droplets [4]. Lipid storage diseases are also characterized by intramuscular lipid accumulation and by impaired mitochondrial bioenergetics in myocytes, causing progressive myopathy with muscle weakness [36]. Typically, triglyceride droplets are excessively stored in muscle tissue in lipid storage diseases [37].…”

“…Carnitine is effective in treating PCD and MADD. Riboflavin or carnitine is usually beneficial in MADD [36]. Bezafibrate has not been shown to be effective in vivo [92].…”

An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases

“…Alterations in lipid metabolism and storage can cause cardiac and neuromuscular pathologies. In fact, a high accumulation of lipids in muscle affects mitochondrial function, which is linked to the development of myopathies [ 218 ].…”